Cargando…

Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximab

The risk of serious bacterial infectious events (SIEs) after an RTX course used in severe and refractory cases of systemic autoimmune diseases (SAID) is well known. Risk factors for SIEs merit investigation. For this case–control study, data were collected in a single centre of internal medicine and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heusele, Marion, Clerson, Pierre, Guery, Benoit, Lambert, Marc, Launay, David, Lefevre, Guillaume, Morell-Dubois, Sandrine, Maillard, Hélène, Le Gouellec, Noémie, Hatron, Pierre-Yves, Hachulla, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer London 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058071/ https://www.ncbi.nlm.nih.gov/pubmed/24487486 http://dx.doi.org/10.1007/s10067-014-2509-2

Ejemplares similares

Predictors of lung function test severity and outcome in systemic sclerosis-associated interstitial lung disease
por: Le Gouellec, Noémie, et al.
Publicado: (2017)

Clinical Characteristics and Outcome of Patients with Infective Endocarditis Diagnosed in a Department of Internal Medicine
por: Kreitmann, Louis, et al.
Publicado: (2020)

Factors associated with the 6-minute walk distance in patients with systemic sclerosis
por: Sanges, Sébastien, et al.
Publicado: (2017)

Relevance of Partitioning DLCO to Detect Pulmonary Hypertension in Systemic Sclerosis
por: Sivova, Nadia, et al.
Publicado: (2013)

Association between Routine Laboratory Parameters and the Severity and Progression of Systemic Sclerosis
por: Chikhoune, Liticia, et al.
Publicado: (2022)

Activities of Clinical Expertise and Research in a Rare Disease Referral Centre: A Place for Telemedicine beyond the COVID-19 Pandemic?
por: Ducrocq, Quentin, et al.
Publicado: (2023)

Effect of In Vitro and In Vivo Anakinra on Cytokines Production in Schnitzler Syndrome
por: Launay, David, et al.
Publicado: (2013)

Raising rare disease awareness using red flags, role play simulation and patient educators: results of a novel educational workshop on Raynaud phenomenon and systemic sclerosis
por: Sanges, S., et al.
Publicado: (2020)

Giant cell arteritis-related cerebrovascular ischemic events: a French retrospective study of 271 patients, systematic review of the literature and meta-analysis
por: Penet, Thomas, et al.
Publicado: (2023)

Activités de recours et de recherche d’un service de Médecine Interne : une place pour la télémédecine, au-delà de la pandémie COVID-19 ?
por: Ducrocq, Q., et al.
Publicado: (2021)

Fatal Enterovirus-related Myocarditis in a Patient with Devic’s Syndrome Treated with Rituximab
por: Diarra, Ava, et al.
Publicado: (2021)

Prevalence and Clinical Associations of Antiphospholipid Antibodies in Systemic Sclerosis: New Data From a French Cross-Sectional Study, Systematic Review, and Meta-Analysis
por: Sobanski, Vincent, et al.
Publicado: (2018)

Acquired Hemophilia A in IgG4-Related Disease: Case Report, Immunopathogenic Study, and Review of the Literature
por: Sanges, Sébastien, et al.
Publicado: (2020)

High-Grade Salivary-Gland Involvement, Assessed by Histology or Ultrasonography, Is Associated with a Poor Response to a Single Rituximab Course in Primary Sjögren’s Syndrome: Data from the TEARS Randomized Trial
por: Cornec, Divi, et al.
Publicado: (2016)

(18)F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study
por: Ledoult, Emmanuel, et al.
Publicado: (2021)

Survival in systemic sclerosis-associated pulmonary arterial hypertension in the modern management era
por: Launay, David, et al.
Publicado: (2013)

Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review
por: Leurs, Amélie, et al.
Publicado: (2019)

Efficacy of sildenafil on ischaemic digital ulcer healing in systemic sclerosis: the placebo-controlled SEDUCE study
por: Hachulla, Eric, et al.
Publicado: (2016)

B Cell Homeostasis and Functional Properties Are Altered in an Hypochlorous Acid-Induced Murine Model of Systemic Sclerosis
por: Sanges, Sébastien, et al.
Publicado: (2017)

Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients
por: Hachulla, A-L, et al.
Publicado: (2009)

Pulmonary arterial hypertension in idiopathic inflammatory myopathies: Data from the French pulmonary hypertension registry and review of the literature
por: Sanges, Sébastien, et al.
Publicado: (2016)

Functional outcome and prognostic factors in anti-Jo1 patients with antisynthetase syndrome
por: Marie, Isabelle, et al.
Publicado: (2013)

Systemic Vasculitis During the Course of Systemic Sclerosis: Report of 12 Cases and Review of the Literature
por: Quéméneur, Thomas, et al.
Publicado: (2013)

Rituximab for Autoimmune Encephalitis with Epilepsy
por: Kurukumbi, Mohankumar, et al.
Publicado: (2020)

Rituximab Associated Hypogammaglobulinemia in Autoimmune Disease
por: Tieu, Joanna, et al.
Publicado: (2021)

The Lymphoid Variant of Hypereosinophilic Syndrome: Study of 21 Patients With CD3-CD4+ Aberrant T-Cell Phenotype
por: Lefèvre, Guillaume, et al.
Publicado: (2014)

Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients
por: Ebbo, Mikael, et al.
Publicado: (2017)

Rhodococcus erythropolis Encephalitis in Patient Receiving Rituximab
por: Bagdure, Satish R., et al.
Publicado: (2012)

Cold autoimmune hemolytic anemia resolved by rituximab
por: Palombi, Massimiliano, et al.
Publicado: (2010)

A Case of Autoimmune Hepatitis Treated with Rituximab
por: Barth, E., et al.
Publicado: (2010)

Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin
por: Ahmed, A. Razzaque, et al.
Publicado: (2018)

Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy
por: Boudreault, Katherine, et al.
Publicado: (2017)

Treatment of Refractory Pediatric Autoimmune Hepatitis With Rituximab
por: Saul, Samantha A., et al.
Publicado: (2021)

Risk factors for death and the 3-year survival of patients with systemic sclerosis: the French ItinérAIR-Sclérodermie study
por: Hachulla, Eric, et al.
Publicado: (2009)

Neoehrlichia mikurensis Causing Thrombosis and Relapsing Fever in a Lymphoma Patient Receiving Rituximab
por: Sjöwall, Johanna, et al.
Publicado: (2021)

Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry
por: Salmon, J H, et al.
Publicado: (2015)

Rituximab Monotherapy versus Rituximab and Bortezomib Combination Therapy for Treatment of Non-paraneoplastic Autoimmune Retinopathy
por: Maleki, Arash, et al.
Publicado: (2022)

Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases
por: Khojah, Amer M., et al.
Publicado: (2019)

Rituximab Use in Warm and Cold Autoimmune Hemolytic Anemia
por: Murakhovskaya, Irina
Publicado: (2020)

Rituximab rescue therapy for autoimmune pulmonary alveolar proteinosis
por: Bird, Daniel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vo9ovmrjlqq2m81r7fk7sjbg38